Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism
- 1 January 1993
- Vol. 14, 85-87
- https://doi.org/10.1016/8756-3282(93)90357-g
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Consequences of a hip fracture: A prospective study over 1 yearOsteoporosis International, 1993
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.BMJ, 1992
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992
- Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.BMJ, 1992
- Bone-density measurementThe Lancet, 1992
- Non-trauma mortality in elderly women with low bone mineral densityThe Lancet, 1991
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981